Cardiovascular Effects of Continuous Positive Airway Pressure in Patients with Heart Failure and Obstructive Sleep Apnea
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Obstructive sleep apnea subjects the failing heart to adverse hemodynamic and adrenergic loads and may thereby contribute to the progression of heart failure. We hypothesized that treatment of obstructive sleep apnea by continuous positive airway pressure in patients with heart failure would improve left ventricular systolic function. METHODS: Twenty-four patients with a depressed left ventricular ejection fraction (45 percent or less) and obstructive sleep apnea who were receiving optimal medical treatment for heart failure underwent polysomnography. On the following morning, their blood pressure and heart rate were measured by digital photoplethysmography, and left ventricular dimensions and left ventricular ejection fraction were assessed by echocardiography. The subjects were then randomly assigned to receive medical therapy either alone (12 patients) or with the addition of continuous positive airway pressure (12 patients) for one month. The assessment protocol was then repeated. RESULTS: In the control group of patients who received only medical therapy, there were no significant changes in the severity of obstructive sleep apnea, daytime blood pressure, heart rate, left ventricular end-systolic dimension, or left ventricular ejection fraction during the study. In contrast, continuous positive airway pressure markedly reduced obstructive sleep apnea, reduced the daytime systolic blood pressure from a mean (+/-SE) of 126+/-6 mm Hg to 116+/-5 mm Hg (P=0.02), reduced the heart rate from 68+/-3 to 64+/-3 beats per minute (P=0.007), reduced the left ventricular end-systolic dimension from 54.5+/-1.8 to 51.7+/-1.2 mm (P=0.009), and improved the left ventricular ejection fraction from 25.0+/-2.8 to 33.8+/-2.4 percent (P<0.001). CONCLUSION: In medically treated patients with heart failure, treatment of coexisting obstructive sleep apnea by continuous positive airway pressure reduces systolic blood pressure and improves left ventricular systolic function. Obstructive sleep apnea may thus have an adverse effect in heart failure that can be addressed by targeted therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In small and select groups of patients with OSA and hFrEF, CPAP has been associated with reduced systolic BP743,744 and heart rate,743 small but inconsistent changes in left ventricular EF (LVEF),743–747 decreased overnight urinary norepinephrine excretion,746 improved QOL,743,746 improved mean sleep-related SaO2,745 and decreased pulmonary artery systolic pressure.747”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [743]
Citations
Cites
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Sleep-disordered Breathing and Cardiovascular Disease
SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., & SAMET, J. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2001008 · Cited by 2,901
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01683-7 · Cited by 1,912
Committee Members, Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldmanmd, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., et al. (2001) · Circulation · doi:10.1161/hc4901.102568 · Cited by 1,442
Research works printed but not linked: 1
- Daly PA, 1990, Circulation, 82, I
Cited by
Items 201–300 of 1,000
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 80
Obstructive sleep apnea and cardiovascular disease, a story of confounders!
Collen, J. F., Lettieri, C. J., Wickwire, E. M., & Holley, A. B. (2020) · Sleep And Breathing · doi:10.1007/s11325-019-01945-w · Cited by 81
“Among patients whose sleep-disordered breathing responds to PAP (reduction in AHI), improvements in LVEF and pulmonary pressures occur in as little as 12 weeks [27, 62, 73, 74].”
BackgroundProgressive Regression of Left Ventricular Hypertrophy Two Years after Bariatric Surgery
Algahim, M. F., Lux, T. R., Leichman, J. G., Boyer, A. F., Miller, C. C., Laing, S. T., Wilson, E. B., Scarborough, T., Yu, S., Snyder, B., et al. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.020 · Cited by 76
Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application
Sanders, M. H., Montserrat, J. M., Farré, R., & Givelber, R. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-150mg · Cited by 75
Obstructive Sleep Apnea, Stroke, and Cardiovascular Diseases
Bagai, K. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181f097cb · Cited by 84
Importance and management of chronic sleep apnoea in cardiology
Jaffe, L. M., Kjekshus, J., & Gottlieb, S. S. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs046 · Cited by 74
Red Cell Distribution Width in Patients with Obstructive Sleep Apnea Syndrome
Özsu, S., Abul, Y., Gülsoy, A., Bülbül, Y., Yaman, S., & Özlü, T. (2012) · Lung · doi:10.1007/s00408-012-9376-x · Cited by 74
“Continuous positive airway pressure (CPAP) therapy has the potential to decrease cardiovascular morbidity and mortality in OSAS [43–45].”
BackgroundThe Impact of Cardiac Resynchronization Therapy on Obstructive Sleep Apnea in Heart Failure Patients
Stanchina, M. L., Ellison, K., Malhotra, A., Anderson, M. T., KIRK, M. M., Benser, M. E., Tosi, C., Carlisle, C. C., Millman, R. P., & Buxton, A. E. (2007) · CHEST Journal · doi:10.1378/chest.06-2509 · Cited by 82
Sleep Disorders Are Underdiagnosed in Patients on Maintenance Hemodialysis
Gámez, B. J., Martín‐Malo, A., Alvarez-Lara, M. A., Muñoz, L., Cosano, A., & Aljama, P. (2006) · Nephron Clinical Practice · doi:10.1159/000096982 · Cited by 78
“and systolic function of the left ventricle in heart failure patients [”
BackgroundCardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
Metra, M., Zacà, V., Parati, G., Agostoni, P., Bonadies, M., Ciccone, M. M., Dei, A., Iacoviello, M., Lagioia, R., Lombardi, C., et al. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834058d1 · Cited by 80
Yamamoto, U., Mohri, M., Shimada, K., Origuchi, H., Miyata, K., Ito, K., Abe, K., & Yamamoto, H. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.08.001 · Cited by 73
Cowie, M., Woehrle, H., Wegscheider, K., Vettorazzi, E., Lezius, S., Köenig, W., Weidemann, F., Smith, G. C., Angermann, C., d’Ortho, M., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1048 · Cited by 75
Jessup, M. L., Banner, N. R., Brozena, S. C., Campana, C., Costard‐Jäckle, A., Dengler, T. J., Hunt, S. A., Metra, M., Rahmel, A. O., Renlund, D. G., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.007 · Cited by 76
Sleep Apnea, Heart Failure, and Pulmonary Hypertension
Javaheri, S., Javaheri, S., & Javaheri, A. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0167-3 · Cited by 72
Yoshinaga, K., Burwash, I. G., Leech, J. A., Haddad, M., Johnson, C. B., deKemp, R. A., Garrard, L., Chen, L., Williams, K., DaSilva, J. N., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.059 · Cited by 77
Therapeutic applications of circadian rhythms for the cardiovascular system
Tsimakouridze, E. V., Alibhai, F. J., & Martino, T. A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00077 · Cited by 79
Sun, H. X., Shi, J., Li, M., & Chen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062298 · Cited by 78
“1% after 3 months, which was lower than the 9% improvement reported after 1 month [38].”
BackgroundPaulitsch, F. D. S., & Zhang, L. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2018.09.030 · Cited by 76
“Characteristics of included trials Study ID and Country Participants (Inclusion Criteria) Intervention and control Duration of treatment Outcomes and time-points of assessment Kaneko 2003[17], two centers, Canada Patients (mean age: 55.5 yr; male: 87”
BackgroundInfluentialYumino, D., Wang, H., Floras, J. S., Newton, G. E., Mak, S. S., Ruttanaumpawan, P., Parker, J. D., & Bradley, T. D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.09.037 · Cited by 70
Self-citationManiaci, A., Lavalle, S., Parisi, F. M., Barbanti, M., Cocuzza, S. G., Iannella, G., Magliulo, G., Pace, A., Lentini, M., Masiello, E., et al. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11070204 · Cited by 78
“CPAP treatment has been demonstrated to attenuate myocardial remodeling and improve cardiac function in patients with OSA [62,63].”
BackgroundKasai, T., Narui, K., Dohi, T., Takaya, H., Yanagisawa, N., Dungan, G. C., Ishiwata, S., Ohno, M., Ymaguchi, T., & Momomura, S. (2006) · Circulation Journal · doi:10.1253/circj.70.1148 · Cited by 70
Diagnosis of Obstructive Sleep Apnea Using Pulse Oximeter Derived Photoplethysmographic Signals
Romem, A., Romem, A., Koldobskiy, D. H., & Scharf, S. M. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.3530 · Cited by 75
Farrell, P. C., & Richards, G. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1211-y · Cited by 63
“Congestive heart failure Two randomized trials evaluating the effect of CPAP therapy in patients with OSA and HF showed significant improvements in left ventricular ejection fraction (LVEF) after 1 and 3 months and improved quality of life [98, 101].”
BackgroundPépin, J., Chouri-Pontarollo, N., Tamisier, R., & Levy, P. A. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.10.003 · Cited by 70
Nocturnal Noninvasive Ventilation
Ozsancak, A., D’Ambrosio, C. M., & Hill, N. S. (2008) · CHEST Journal · doi:10.1378/chest.07-1527 · Cited by 76
Randerath, W. J., Galetke, W., Kenter, M., Richter, K., & Schäfer, T. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.09.017 · Cited by 68
“it has been demonstrated that CPAP attenuates central breathing disturbances during sleep and improves heart function and quality of life in heart failure patients with OSAS [4–16].”
BackgroundSleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients
Masuda, T., Murata, M., Honma, S., Iwazu, Y., Sasaki, N., Ogura, M., Ōnishi, A., Ando, Y., Muto, S., Shimada, K., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq756 · Cited by 74
“Continuous positive airway pressure is a standard treatment for obstructive sleep apnea, which improves hypertension, left ventricular systolic function and cardiovascular prognosis [35, 38, 52].”
BackgroundAccuracy of Monitoring for Sleep-Related Breathing Disorders in the Coronary Care Unit
Skinner, M. A., Choudhury, M. S., Homan, S., Cowan, J. O., WILKINS, G. T., & Taylor, D. R. (2005) · CHEST Journal · doi:10.1378/chest.127.1.66 · Cited by 71
Sharples, L., Glover, M., Clutterbuck-James, A., Bennett, M., Jordan, J., Chadwick, R., Pittman, M., East, C., Cameron, M., Davies, M., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18670 · Cited by 63
CPAP Should Not Be Used for Central Sleep Apnea in Congestive Heart Failure Patients
Javaheri, S. (2006) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26653 · Cited by 67
Implications of Obstructive Sleep Apnea for Atrial Fibrillation and Sudden Cardiac Death
GAMI, A. S., & SOMERS, V. K. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01136.x · Cited by 66
Therapy Insight: interactions between atrial fibrillation and obstructive sleep apnea
Gami, A. S., Friedman, P. A., Chung, M. K., Caples, S. M., & Somers, V. K. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0130 · Cited by 71
Obstructive Sleep Apnea and the Risk for Cardiovascular Disease
Kohli, P., Balachandran, J. S., & Malhotra, A. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0161-8 · Cited by 77
“[46], in a study of 24 patients with an ejection fraction (EF) <45% and OSA, found that over a period of 1 month CPAP increased mean EF by 9% and lowered morning systolic blood pressure and heart rate (Table 2).”
BackgroundIn-Hospital Treatment of Obstructive Sleep Apnea During Decompensation of Heart Failure
Khayat, R., Abraham, W. T., Patt, B. T., Pu, M., & Jarjoura, D. G. (2009) · CHEST Journal · doi:10.1378/chest.09-0597 · Cited by 69
Sleep Disordered Breathing in Patients with Acute Coronary Syndromes
Schiza, S. E., SIMANTIRAKIS, E. N., Bouloukaki, I., Mermigkis, C. M., Kallergis, E. M., Chrysostomakis, S. I., Arfanakis, D., Tzanakis, Ν., Vardas, P. E., & Siafakas, N. M. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.1652 · Cited by 331
“8,9 Treatment of OSAHS with CPAP has positive results on its well-known cardiovascular consequences.”
Yoshihisa, A., Shimizu, T., Owada, T., Nakamura, Y., Iwaya, S., Yamauchi, H., Miyata, M., Hoshino, Y., Sato, T., Suzuki, S., et al. (2011) · International Heart Journal · doi:10.1536/ihj.52.218 · Cited by 67
Alkhalil, M., Schulman, E. S., & Getsy, J. E. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60309-2 · Cited by 64
Sleep apnea and atrial fibrillation; 2012 update
C Digby, G., & Baranchuk, A. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760811 · Cited by 63
A Portable Automated Assessment Tool for Sleep Apnea Using a Combined Holter-Oximeter
(2008) · Sleep · doi:10.5665/sleep/31.10.1432 · Cited by 64
Reverse remodeling in heart failure ? fact or fiction?
Pieske, B. M. (2004) · European Heart Journal Supplements · doi:10.1016/j.ehjsup.2004.05.019 · Cited by 62
Celec, P., Hodosy, J., Behuliak, M., Pálffy, R., Gardlík, R., Halčák, L., & Mucska, I. (2011) · Sleep And Breathing · doi:10.1007/s11325-011-0510-4 · Cited by 63
Khayat, R., Small, R. S., Rathman, L. D., Krueger, S., Gocke, B., Clark, L., Yamokoski, L. M., & Abraham, W. T. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.04.005 · Cited by 64
Obstructive Sleep Apnea and its Relationship to Cardiac Arrhythmias
ARIAS, M. A., & SÁNCHEZ, A. M. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00891.x · Cited by 62
Respiratory–cardiovascular interactions
Fisher, J. P., Żera, T., & Paton, J. F. R. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91534-2.00006-0 · Cited by 71
Luboshitzky, R., Lavie, L., Shen‐Orr, Z., & Lavie, P. (2003) · PubMed · Cited by 67
Naughton, M. T., & Lorenzi‐Filho, G. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.02.001 · Cited by 68
Positive airway pressure therapy for heart failure
Kato, T., Suda, S., & Kasai, T. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i11.1175 · Cited by 64
CSI position statement on management of heart failure in India
Guha, S., Harikrishnan, S., Ray, S., Sethi, R., Ramakrishnan, S., Banerjee, S., Bahl, V. K., Goswami, K. C., Banerjee, A. K., Shanmugasundaram, S., et al. (2018) · Indian Heart Journal · doi:10.1016/j.ihj.2018.05.003 · Cited by 65
Left Ventricular Structural Adaptations to Obstructive Sleep Apnea in Dilated Cardiomyopathy
Usui, K., Parker, J. D., Newton, G. E., Floras, J. S., Ryan, C. M., & Bradley, T. D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-320oc · Cited by 58
“Because treatment of OSA by continuous positive airway pressure in patients with HF causes marked improvements in LV systolic function ( 9 , 10), our findings also suggest the potential for therapy for OSA to contribute to reverse remodeling of the left ventricle in patients with nonischemic dilated cardiomyopathy.”
BackgroundSelf-citationCardiovascular Disorders Associated with Obstructive Sleep Apnea
(2011) · Advances in cardiology · doi:10.1159/000325110 · Cited by 65
Sleep Disordered Breathing and Heart Failure
Cowie, M., & Gallagher, A. M. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.06.016 · Cited by 70
VersorgungsLeitlinie, N. (2011) · Cited by 58
Chronic obstructive sleep apnea causes atrial remodeling in canines: mechanisms and implications
Zhao, J., Xu, W., Yun, F., Zhao, H., Li, W., Gong, Y., Yuan, Y., Yan, S. R., Zhang, S., Ding, X., et al. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0427-8 · Cited by 60
Sleep apnoea in heart failure: To treat or not to treat?
Naughton, M. T., & Kee, K. (2017) · Respirology · doi:10.1111/resp.12964 · Cited by 53
Cardiovascular Disease Risk in Obstructive Sleep apnea: An Update
Yacoub, M., Youssef, I., Salifu, M. O., & McFarlane, S. I. (2018) · Journal of Sleep Disorders & Therapy · doi:10.4172/2167-0277.1000283 · Cited by 65
“In the first randomized control study of 24 patients with severe systolic heart failure and OSA, the use of CPAP for one month showed a 9% improvement in left ventricular ejection fraction, compared to usual medical care, and reduced daytime systolic BP and HR [27].”
BackgroundKhayat, R., Abraham, W. T., Patt, B. T., Roy, M., Hua, K., & Jarjoura, D. G. (2008) · CHEST Journal · doi:10.1378/chest.08-0346 · Cited by 66
Periodicity of Obstructive Sleep Apnea in Patients With and Without Heart Failure
Ryan, C. M., & Bradley, T. D. (2005) · CHEST Journal · doi:10.1378/chest.127.2.536 · Cited by 65
Self-citationSleep-disordered breathing in heart failure: characteristics and implications
Lanfranchi, P. A., & Somers, V. K. (2003) · Respiratory Physiology & Neurobiology · doi:10.1016/s1569-9048(03)00078-8 · Cited by 59
The interactions between respiratory and cardiovascular systems in systolic heart failure
Cross, T. J., Kim, C., Johnson, B. D., & Lalande, S. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00113.2019 · Cited by 64
Central and peripheral sympathetic activation in heart failure
Grassi, G. M., Mancia, G., & Esler, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab222 · Cited by 57
Sleep Disturbance in People With Heart Failure: Implications for Self-care
Redeker, N. S. (2008) · The Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000305094.20012.76 · Cited by 65
Ruttanaumpawan, P., Gilman, M. P., Usui, K., Floras, J. S., & Bradley, T. D. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282fb81ed · Cited by 58
Self-citationImpact of obstructive sleep apnea on left atrial functional and structural remodeling beyond obesity
Kim, S.-M., Cho, K. I., Kwon, J., Lee, H. G., & Kim, T.-I. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.07.007 · Cited by 58
“Several studies have demonstrated that obstructive sleep apnea OSA) is an independent risk factor for cardiovascular morbidity nd mortality [1–3], and left ventricular (LV) diastolic function is ften impaired in OSA [4,5].”
BackgroundOlafiranye, O., Akinboboye, O., Mitchell, J. E., Ogedegbe, G. G., & Jean‐Louis, G. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.12.018 · Cited by 57
Mechanisms of sleep-disordered breathing: causes and consequences
Leung, R. S. T., Comondore, V. R., Ryan, C. M., & Stevens, D. J. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-1055-x · Cited by 62
“Treatment of OSA for 1 month with CPAP has been reported in a randomized controlled trial to improve LV ejection fraction [80] and to reduce both daytime MSNA and BP, compared to an untreated group [207].”
BackgroundReitz, C. J., & Martino, T. A. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150706105926 · Cited by 59
“eral studies report that nocturnal CPAP therapy provides cardiovascular benefits [94, 99-104].”
BackgroundAtrial overdrive pacing compared to CPAP in patients with obstructive sleep apnoea syndrome
Unterberg, C., Lüthje, L., Szych, J., Vollmann, D., Hasenfuß, G., & Andreas, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi448 · Cited by 55
“This is in line with the finding that CPAP therapy in patients with OSA can improve a reduced left ventricular systolic function.(41) There was no significant difference in urinary norepinephrine concentrations between both treatment modalities, suggesting that there was no major negative impact on sympathetic tone.”
ResultObstructive sleep apnea and cardiovascular disease: evidence and underlying mechanisms.
Jean‐Louis, G., Zizi, F., Brown, D., Ogedegbe, G. G., Borer, J. S., & McFarlane, S. I. (2009) · PubMed · Cited by 65
Andrén, A., SJÖQUIST, M., & Tegelberg, Å. (2009) · Journal of Oral Rehabilitation · doi:10.1111/j.1365-2842.2009.01987.x · Cited by 53
OSA: the new cardiovascular disease
Devulapally, K., Pongonis, R., & Khayat, R. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9101-2 · Cited by 59
“Randomized controlled studies in patients with heart failure and OSA demonstrated that CPAP treatment for a few weeks increased left ventricular ejection fraction and decreased blood pressure and sympathetic activation, strongly suggesting a pathogenic role of OSA in worsening cardiac function [15, 109, 110].”
BackgroundNadar, S. K., Prasad, N., Taylor, R. S., & Lip, G. Y. H. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.03.047 · Cited by 53
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 67
Cardiologist’s knowledge and attitudes about obstructive sleep apnea: a survey study
Southwell, C., Moallem, M., & Auckley, D. H. (2008) · Sleep And Breathing · doi:10.1007/s11325-008-0170-1 · Cited by 52
“Treatment with CPAP has been shown to improve left ventricular function as well as the functional status of these patients [13, 14].”
BackgroundCirculating Endothelial Cells and Endothelial Progenitor Cells in Obstructive Sleep Apnea
Martin, K. B., Stanchina, M. L., KOUTTAB, N. M., Harrington, E. O., & Rounds, S. (2008) · Lung · doi:10.1007/s00408-008-9073-y · Cited by 58
“There is evidence of a clear association between obstructive sleep apnea (OSA) and cardiovascular diseases, including hypertension [1], congestive heart failure [2],”
BackgroundObstructive Sleep Apnea Among Adults in Nigeria
Adewole, O., Hakeem, A., Fola, A., Anteyi, E. A., Ajuwon, Z., & Erhabor, G. E. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30983-4 · Cited by 55
Ruttanaumpawan, P., Logan, A. G., Floras, J. S., Bradley, T. D., & for the CANPAP Investigators (2009) · Sleep · doi:10.5665/sleep/32.1.91 · Cited by 52
Self-citationManagement of Obstructive Sleep Apnea-Hypopnea Syndrome: Overview
Phillips, B. A., & Kryger, M. H. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50099-9 · Cited by 56
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. N., Викторович, А. М., Алексеева, Л. И., Almazova, I. I., Andreenko, Е. Y., Antipushina, D. N., Balanova, Y. А., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3996 · Cited by 65
Lip, G. Y. H., Heinzel, F. R., Gaïta, F., González‐Juanatey, J. R., Heuzey, J. Y. L., Potpara, T., Svendsen, J. H., Vos, M. A., Anker, S. D., Coats, A. J. S., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.338 · Cited by 53
“However, OSA has been reported to independently increase the risk of incident AF and AF recurrence post cardioversion or AF ablation.111,112 Oxygen administration and treatment with continuous positive airway pressure alone, or in combination with atrial overdrive pacing, reduce the burden of cardiac arrhythmias and c…”
InfluentialReinhard, W., Plappert, N., Zeman, F., Hengstenberg, C., Riegger, G. A. J., Novack, V., Maimon, N., Pfeifer, M. A., & Arzt, M. E. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.12.014 · Cited by 56
“PSG was performed in all subjects using standard polysomnographic techniques [17].”
MethodDu, Y., Wang, X., Li, L., Hao, W., Zhang, H., Li, Y., Qin, Y., Nie, S., Christopher, T. A., Lopez, B. L., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315067 · Cited by 52
CARDIOVASCULAR MECHANISMS AND CONSEQUENCES OF OBSTRUCTIVE SLEEP APNOEA
Vrints, H., Shivalkar, B., Heuten, H., Vanderveken, O. M., Hamans, E., de Heyning, P. V., Backer, W. D., & Verbraecken, J. A. (2013) · Acta Clinica Belgica · doi:10.2143/acb.2981 · Cited by 50
Obstructive sleep apnoea in acute coronary syndrome
Randerath, W. J., Bonsignore, M. R., & Herkenrath, S. D. (2019) · European Respiratory Review · doi:10.1183/16000617.0114-2018 · Cited by 53
Caples, S. M., Wolk, R., & Somers, V. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00676.2005 · Cited by 49
Calero, G., Farré, R., Ballester, E., Hernández, L., Navajas, D., & Montserrat, J. M. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2005.09.016 · Cited by 53
The effect of obstructive sleep apnea on chronic medical disorders.
Collop, N. A. (2007) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.74.1.72 · Cited by 53
Kim, K.-J., Cho, H., Kim, M., Kang, J., Kim, K., Kim, D., Seo, S. M., Yang, J. H., Cha, M., Choi, J., et al. (2019) · International Journal of Heart Failure · doi:10.36628/ijhf.2019.0002 · Cited by 50
Treatment of Obstructive Sleep Apnea Syndrome
Freedman, N. S. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.02.012 · Cited by 52
Sleep-disordered breathing and cardiovascular disease
Benjamin, J. A., & Lewis, K. E. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.062836 · Cited by 95
Yoshihisa, A., Suzuki, S., Miyata, M., Yamaki, T., Sugimoto, K., Kunii, H., Nakazato, K., Suzuki, H., Saitoh, S., & Takeishi, Y. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0453 · Cited by 50
Dursunoğlu, N., Dursunoğlu, D., Özkurt, S., Kuru, Ö., Gür, Ş., Kıter, G., & Evyapan, F. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.04.007 · Cited by 47
“Furthermore, randomised trials involving patients with HF have shown that treatment of co-existing OSA by CPAP improves daytime LVEF [26,27].”
BackgroundJohnson, C. B., Beanlands, R. S., Yoshinaga, K., Haddad, M., Leech, J. A., de Kemp, R., & Burwash, I. G. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70668-8 · Cited by 54
“CPAP compliance was assessed using built-in hour meters in the CPAP machines to determine use (23,40).”
BackgroundMethodInfluentialConsequences of Obstructive Sleep Apnea
Khayat, R., & Pleister, A. P. (2016) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2016.05.002 · Cited by 52
García‐Touchard, A., Somers, V. K., Olson, L. J., & Caples, S. M. (2008) · CHEST Journal · doi:10.1378/chest.07-0871 · Cited by 46
Vazir, A., Hastings, P. C., Papaioannou, I., Poole-Wilson, P. A., Cowie, M., Morrell, M. J., & Simonds, A. K. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.01.015 · Cited by 46
“There is a growing body of evidence to suggest that it is beneficial to treat OSA in CHF patients using continuous positive airway pressure (CPAP) therapy.(10,11) However, the optimal treatment for CSA remains unclear, in light of the results of the CANPAP study.”
Sleep symptoms and clinical markers of illness in patients with heart failure
Príncipe-Rodríguez, K., Strohl, K. P., Hadziefendic, S., & Piña, I. L. (2005) · Sleep And Breathing · doi:10.1007/s11325-005-0023-0 · Cited by 49
“Treatment of sleepdisordered breathing with continuous positive airway pressure (CPAP) has been shown to improve cardiac function in patients with HF [18–24].”
BackgroundSharma, S., Mather, P. J., Gupta, A., Reeves, G. R., Rubin, S., Bonita, R. E., Chowdhury, A., Malloy, R., Willes, L., & Whellan, D. J. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.032 · Cited by 46
Gunta, S. P., Jakulla, R. S., Ubaid, A., Mohamed, K., Bhat, A., López‐Candales, A., & Norgard, N. B. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/6006127 · Cited by 51
“In a randomized trial involving 24 moderate-severe OSA patients with HF with reduced ejection fraction, 30 days of CPAP treatment led to an improvement in left ventricular systolic function, significantly increasing the echocardiographic assessed ejection fraction by 9% [104].”
BackgroundDesai, A. S., & Fang, J. C.-T. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2007.11.001 · Cited by 46
Damy, T., Paulino, A., Margarit, L., Drouot, X., Stoica, M. A., Vermès, E., Guéret, P., Adnot, S., Dubois‐Randé, J., d’Ortho, M., et al. (2010) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2009.00817.x · Cited by 47
“Treatment of SDB by nocturnal respiratory support improves LV systolic dysfunction in both patterns (Granton et al., 1996; Kaneko et al., 2003; Mansfield et al., 2004; Naughton et al., 1995; Philippe et al., 2006; Shivalkar et al., 2006; Sin et al., 2000), demonstrating the causal effect of SDB on LV impairment.”
Background
Metadata
- Authors
- Kaneko, Y., Floras, J. S., Usui, K., Plante, J., Tkacova, R., Kubo, T., Ando, S.-I., & Bradley, T. D.
- Affiliations
- University of Toronto (CA)
- Mount Sinai Hospital (CA)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-03-27
- Volume
- 348
- Issue
- 13
- Pages
- 1233-1241
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2022358071
- Cited by
- 1,051
- References
- 40
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 13 · 2023: 24 · 2022: 26 · 2021: 19 · 2020: 22 · 2019: 26 · 2018: 34 · 2017: 43 · 2016: 45 · 2015: 60 · 2014: 48 · 2013: 61 · 2012: 51
- FWCI
- 39.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- continuous positive airway pressure, obstructive sleep apnea, heart failure, left ventricular systolic function, left ventricular ejection fraction, systolic blood pressure, heart rate, left ventricular end-systolic diameter, hemodynamic load
- MeSH terms
- Blood Pressure, Cardiomyopathy, Dilated, Female, Heart Rate, Humans, Male, Middle Aged, Positive-Pressure Respiration, Stroke Volume, Systole, Ventricular Function, Left, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.